---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-25-007750"
form_type: "8-K"
ticker: "SNOA"
cik: "0001367083"
company_name: "Sonoma Pharmaceuticals, Inc."
filed_at: "2025-10-23T23:59:59+00:00"
generated_at: "2026-05-17T02:28:43.653218+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Sonoma Pharma terminates EVP/COO Bruce Thornton for cause, effective Oct 18

## Summary
- Bruce Thornton terminated as EVP and Chief Operating Officer on October 18, 2025.
- Termination was for cause under his employment agreement; no severance or future benefits.
- Thornton will only receive salary and benefits earned through the termination date.
- CEO Amy Trombly signed the 8-K confirming the departure.

## SEC filing metadata
- accession: 0001683168-25-007750
- form_type: 8-K
- ticker: SNOA
- cik: 0001367083
- company_name: Sonoma Pharmaceuticals, Inc.
- filed_at: 2025-10-23T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1367083/000168316825007750/0001683168-25-007750-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1367083/000168316825007750/sonoma_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-25-007750
- JSON: https://secwatch.observer/filing/0001683168-25-007750.json
- Plain text: https://secwatch.observer/filing/0001683168-25-007750.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.